MARC details
000 -LEADER |
fixed length control field |
04795cam a22007934a 4500 |
001 - CONTROL NUMBER |
control field |
ocm48629668 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220712163626.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr bn||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
010601s1999 dcu ob 000 0 eng |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
NLM |
Language of cataloging |
eng |
Description conventions |
pn |
Transcribing agency |
NLM |
Modifying agency |
N$T |
-- |
YDXCP |
-- |
E7B |
-- |
OCLCF |
-- |
OCLCQ |
-- |
OCLCO |
-- |
OCLCQ |
-- |
AGLDB |
-- |
NLM |
-- |
OCLCO |
-- |
BUF |
-- |
MERER |
-- |
OCLCQ |
-- |
VTS |
-- |
OCLCA |
-- |
STF |
-- |
G3B |
-- |
OCLCQ |
-- |
K6U |
-- |
OCLCO |
-- |
VLY |
-- |
OCLCO |
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
Record control number |
101097215 |
Source |
DNLM |
019 ## - |
-- |
47216537 |
-- |
58678207 |
-- |
58678227 |
-- |
83302566 |
-- |
726823299 |
-- |
906465512 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0309583012 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780309583015 |
029 0# - (OCLC) |
OCLC library identifier |
NLM |
System control number |
101097215 |
029 1# - (OCLC) |
OCLC library identifier |
DEBBG |
System control number |
BV043142237 |
029 1# - (OCLC) |
OCLC library identifier |
DEBSZ |
System control number |
422347310 |
029 1# - (OCLC) |
OCLC library identifier |
GBVCP |
System control number |
800812417 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)48629668 |
Canceled/invalid control number |
(OCoLC)47216537 |
-- |
(OCoLC)58678207 |
-- |
(OCoLC)58678227 |
-- |
(OCoLC)83302566 |
-- |
(OCoLC)726823299 |
-- |
(OCoLC)906465512 |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
043 ## - GEOGRAPHIC AREA CODE |
Geographic area code |
n-us--- |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC276 |
Item number |
.G45 1999eb |
060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QZ 266 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
076000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
030000 |
Source |
bisacsh |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
078000 |
Source |
bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
614.59990973 |
Edition number |
22 |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Gelband, Hellen. |
245 12 - TITLE STATEMENT |
Title |
A report on the sponsors of cancer treatment clinical trials and their approval and monitoring mechanisms / |
Statement of responsibility, etc |
Hellen Gelband ; prepared for the National Cancer Policy Board. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Washington D.C. : |
Name of publisher, distributor, etc |
National Research Council, |
Date of publication, distribution, etc |
1999. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - |
-- |
text |
-- |
txt |
-- |
rdacontent |
337 ## - |
-- |
computer |
-- |
c |
-- |
rdamedia |
338 ## - |
-- |
online resource |
-- |
cr |
-- |
rdacarrier |
500 ## - GENERAL NOTE |
General note |
Title from caption (viewed June 14, 2001). |
500 ## - GENERAL NOTE |
General note |
"February 1999." |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references. |
520 3# - SUMMARY, ETC. |
Summary, etc |
This report for the National Cancer Policy Board (NCPB) describes the procedures currently in place in the United States for approving and monitoring clinical trials of cancer treatments. Virtually all cancer clinical trials are funded by agencies of the federal government or the pharmaceutical industry, so the focus is on the requirements for each of these groups. The paper is intended as a jumping off point for the NCPB to consider some of the pressing policy issues surrounding clinical trials in cancer, though as yet, no specific follow-on projects have been initiated. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
""A Report on the Sponsors of Cancer Treatment Clinical Trials and Their Approval and Monitoring Machanisms""; ""Copyright""; ""Preface""; ""Report Reviewers""; ""Contents""; ""SUMMARY""; ""Cancer Treatment Trial Sponsors""; ""Quality Standards for Cancer Treatment Trials""; ""Common Elements of Clinical Trial Review Criteria""; ""Reviews for Scientific Merit""; ""Reviews and Procedures to Ensure the Safety and Rights of Participants""; ""INTRODUCTION""; ""ELIGIBILITY OF MEDICARE PATIENTS FOR CANCER CLINICAL TRIALS""; ""CRITERIA AND PROCEDURES FOR APPROVING AND MONITORING CLINICAL TRIALS"" |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
""The Two Prongs of Clinical Trial Protocol Review and Monitoring""""The National Cancer Institute""; ""The Cancer Therapy Evaluation Program""; ""The Cancer Centers Program""; ""Department of Veterans Affairs""; ""The Cooperative Studies Program""; ""VA-Funded Research at Single VA Medical Centers""; ""INSTITUTIONAL REVIEW BOARDS""; ""THE FOOD AND DRUG ADMINISTRATION""; ""The Commercial IND Application""; ""Noncommercial INDs""; ""Protection of Human Subjects""; ""COMMON ELEMENTS OF CLINICAL TRIAL REVIEW CRITERIA""; ""Reviews for Scientific Merit"" |
590 ## - LOCAL NOTE (RLIN) |
Local note |
eBooks on EBSCOhost |
Provenance (VM) [OBSOLETE] |
EBSCO eBook Subscription Academic Collection - Worldwide |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Treatment. |
9 (RLIN) |
176307 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Oncology |
General subdivision |
Research. |
9 (RLIN) |
292662 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Clinical trials. |
9 (RLIN) |
163655 |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Neoplasms |
General subdivision |
therapy |
9 (RLIN) |
853325 |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Clinical Trials as Topic |
General subdivision |
standards |
9 (RLIN) |
1326334 |
651 #2 - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME |
Geographic name |
United States |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Clinical Trials as Topic |
9 (RLIN) |
540517 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Traitement. |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancérologie |
General subdivision |
Recherche. |
9 (RLIN) |
1326335 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Études cliniques. |
9 (RLIN) |
924559 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
MEDICAL |
General subdivision |
Preventive Medicine. |
Source of heading or term |
bisacsh |
9 (RLIN) |
865758 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
MEDICAL |
General subdivision |
Forensic Medicine. |
Source of heading or term |
bisacsh |
9 (RLIN) |
869543 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
MEDICAL |
General subdivision |
Public Health. |
Source of heading or term |
bisacsh |
9 (RLIN) |
88034 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Treatment. |
Source of heading or term |
fast |
-- |
(OCoLC)fst00845538 |
9 (RLIN) |
176307 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Clinical trials. |
Source of heading or term |
fast |
-- |
(OCoLC)fst00864429 |
9 (RLIN) |
163655 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Oncology |
General subdivision |
Research. |
Source of heading or term |
fast |
-- |
(OCoLC)fst01045744 |
9 (RLIN) |
292662 |
655 #0 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books. |
655 #4 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
National Cancer Policy Board (U.S.) |
9 (RLIN) |
1287244 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=123575">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=123575</a> |
938 ## - |
-- |
ebrary |
-- |
EBRY |
-- |
ebr10071932 |
938 ## - |
-- |
EBSCOhost |
-- |
EBSC |
-- |
123575 |
938 ## - |
-- |
YBP Library Services |
-- |
YANK |
-- |
2294038 |
994 ## - |
-- |
92 |
-- |
INOPJ |